# Cimpress share price today (Cimpress plc, CMPR)

> Cimpress plc's balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. CMPR · Industrials · Specialty Business Services · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/cmpr

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $59.10 (−14.6% in a year)
- P/E: 17.4× (lower than 64% of the last 2.8 years)
- Revenue (Jun 2026): $945 M (+8.7% on a year ago)
- Profit (Jun 2026): $25.1 M
- Operating margin: 6.3% (−2.1 points on a year ago)
- ROE: −24%, FY26
- ROIC: 10.4%, against a 8.6% cost of capital: +1.8 points
- Profit that came in as cash: 328%, last 3 years

The main question: yearly earnings per share moved +553.4% while the share price moved −14.6%. ## What is the Cimpress share price today? Cimpress plc's share price was $59.10 at the close on 3 November 2026. It has been moving sideways for 8 weeks. That is 29.8% below its average price over the last 200 trading days. In the last 52 weeks it traded between $57 and $103, and at that close it sat 5% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 14 weeks running. Over the last 10 years the share price moved −38% while the S&P 500 moved +255%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 31 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Cimpress pay? Cimpress plc pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Cimpress on? Cimpress is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Cimpress profitable? Cimpress plc earned $25.1 M of net profit in the Jun 2026 quarter. Full-year FY26 profit was $95.9 M. That is 2.7% of the quarter's revenue. The same quarter a year earlier lost $25.3 M. 4 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was $95.9 M (+541.2% on the year before). ## How much revenue does Cimpress make, and is it growing? Cimpress plc reported $945 M of revenue in the Jun 2026 quarter, +8.7% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 5 years it has grown 7.7% a year on average. The last full year, FY26, came in at $3.7 B. The last four reported quarters add to $3.7 B. FY26 revenue was $3.7 B, +9.8% on the year before. Recent pace: the last four quarters grew +9.8% on average, against 7.7% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +9.8%, against +6.5% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +541.2%, against −25.7% a year (accelerating). ## How much of every $100 of sales does Cimpress keep? Cimpress plc's operating margin was 6.3% in the Jun 2026 quarter, 2.1 percentage points lower than the same quarter a year ago. Across 6 years it has been between 2.1% and 7.5%. The latest quarter is within that range. Why the margin moved: operating margin changed −2.1 percentage points on the year while gross margin changed −2.7 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Cimpress' profit turning into cash? Over the last 3 years, 328% of Cimpress plc's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in $284 M of operating cash against $95.9 M of profit. After $100 M of spending on assets, $183 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Cimpress' cash go? Cimpress plc does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $244 M on assets over the last 3 years. Averaged over those years that is 2.2% of FY26 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $244 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Cimpress' P/E ratio, and how does it compare with its own history? Cimpress plc's P/E is 17.4×, in the middle of its own history: higher than 36% of past readings. Its usual P/E (the middle reading) is 26.4×, over 2.8 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +553.4% while the price moved −14.6%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 3 years the price moved −1.8% a year; about +35.6% a year came from earnings growth and about −37.4 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Cimpress business getting better or worse? Cimpress plc's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The return-on-capital line is not shown: net worth is negative, so a return on capital means nothing. The balance sheet is in distress, and this reading uses the growth lines alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Cimpress earn on its capital? Cimpress plc earned a ROE of −24% in FY26. That is up from a low of −34% in FY24. Its return on capital used (ROIC) is 1.8 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 2.6% net margin and 1.70× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 2.6% net margin × 1.70× asset turnover × −5.53× leverage (assets divided by equity) ≈ −24.4% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 10.4% − 8.6% = +1.8 percentage points. The 8.6% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 10.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 12.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Cimpress have too much debt? Cimpress plc's net worth is negative: it owes more than it owns, so a debt-to-equity ratio means nothing here. Year by year, that ratio went from −4.85 in FY21 to −4.49 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Cimpress shareholding pattern? 14.7% of Cimpress plc's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 11.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Cimpress from balance-sheet trouble? For Cimpress plc, the Z-score is 2.48. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.48 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Cimpress rank in its industry? 36.7 out of 100, rank 24 of 30 in Specialty Business Services, with 64% of the evidence available. Cimpress plc scores 36.7 out of 100 against the 30 companies it is compared with in Specialty Business Services, ranking 24. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 12.8 + 13.6 + 9.7 + 0.6 = 36.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Cimpress compared with? Cimpress ranks 24 of 30 Specialty Business Services companies on the 4-Factor Sector Score, with 36.7 out of 100. 1. [Cintas Corporation](https://www.sectoralpha.in/us/stocks/ctas) CTAS · leader · Most evidence points up · 85% evidence 68.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.9/35 · Revenue 9.5% · Profit 11.3% · Operating margin change 1.4 points · 95% evidence Capital efficiency 21.0/25 · ROCE 34.3% · Operating margin 24.1% · 76% evidence Valuation 6.1/20 · P/E 39.3× · PEG 3.17 · 65% evidence Relative strength 17.3/20 · Lead over its industry 3.9% · Lead over S&P 500 11.8% · 1 year 20.9% · 100% evidence · 10 of 12 weeks ahead Exact sum: 23.9 + 21 + 6.1 + 17.3 = 68.3 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [UL Solutions Inc.](https://www.sectoralpha.in/us/stocks/uls) ULS · turning · Most evidence points up · 81% evidence 66.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.0/35 · Revenue 6.6% · Profit 54.4% · Operating margin change 0.7 points · 83% evidence Capital efficiency 20.5/25 · ROCE 26.4% · Operating margin 18.4% · 76% evidence Valuation 13.0/20 · P/E 40.7× · PEG 0.77 · 65% evidence Relative strength 8.1/20 · Lead over its industry -13.8% · Lead over S&P 500 -7.3% · 1 year -6.1% · 100% evidence · 1 of 12 weeks ahead Exact sum: 25 + 20.5 + 13 + 8.1 = 66.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [RELX PLC](https://www.sectoralpha.in/us/stocks/relx) RELX · breaking out · Too little evidence to rank firmly · 51% evidence 65.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.8/35 · Revenue n/a · Profit n/a · Operating margin change 1.1 points · 26% evidence Capital efficiency 21.6/25 · ROCE 36.1% · Operating margin 32% · 76% evidence Valuation 10.4/20 · P/E 18.3× · PEG n/a · 15% evidence Relative strength 13.9/20 · Lead over its industry -2.9% · Lead over S&P 500 4.6% · 1 year -6.8% · 100% evidence · 8 of 12 weeks ahead Exact sum: 19.8 + 21.6 + 10.4 + 13.9 = 65.7 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 4. [ABM Industries Incorporated](https://www.sectoralpha.in/us/stocks/abm) ABM · leader · Evidence leans up · 85% evidence 63.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Revenue 6% · Profit 44% · Operating margin change 0.5 points · 95% evidence Capital efficiency 10.2/25 · ROCE 8.3% · Operating margin 4.3% · 76% evidence Valuation 15.5/20 · P/E 16.9× · PEG 0.33 · 65% evidence Relative strength 17.8/20 · Lead over its industry 6.1% · Lead over S&P 500 14.1% · 1 year 27.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 19.5 + 10.2 + 15.5 + 17.8 = 63 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Cass Information Systems, Inc.](https://www.sectoralpha.in/us/stocks/cass) CASS · quiet · Evidence leans up · 85% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.5/35 · Revenue 6.4% · Profit 21.9% · Operating margin change 0.5 points · 95% evidence Capital efficiency 13.1/25 · ROCE 7.1% · Operating margin 29.7% · 76% evidence Valuation 14.8/20 · P/E 17.9× · PEG 0.72 · 65% evidence Relative strength 10.5/20 · Lead over its industry -1.4% · Lead over S&P 500 5.8% · 1 year 36% · 100% evidence · 5 of 12 weeks ahead Exact sum: 22.5 + 13.1 + 14.8 + 10.5 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Maximus, Inc.](https://www.sectoralpha.in/us/stocks/mms) MMS · breaking out · Evidence leans up · 81% evidence 57.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.1/35 · Revenue -3.3% · Profit 17% · Operating margin change 0.3 points · 83% evidence Capital efficiency 15.8/25 · ROCE 14.6% · Operating margin 12.6% · 76% evidence Valuation 16.2/20 · P/E 7.6× · PEG 0.31 · 65% evidence Relative strength 8.4/20 · Lead over its industry -16.7% · Lead over S&P 500 -10% · 1 year -22.1% · 100% evidence · 1 of 12 weeks ahead Exact sum: 17.1 + 15.8 + 16.2 + 8.4 = 57.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [CBIZ, Inc.](https://www.sectoralpha.in/us/stocks/cbz) CBZ · Evidence leans up · 65% evidence 57.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.6/43.75 · Revenue 3.8% · Profit 34.6% · Operating margin change 2 points · 95% evidence Capital efficiency 13.5/31.25 · ROCE 7.7% · Operating margin 13.3% · 76% evidence Valuation 18.4/25 · P/E 20.7× · PEG 0.4 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 25.6 + 13.5 + 18.4 = 57.5 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 8. [Thomson Reuters Corporation](https://www.sectoralpha.in/us/stocks/tri) TRI · breaking out · Evidence leans up · 81% evidence 56.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 7% · Profit 1.6% · Operating margin change 4.2 points · 83% evidence Capital efficiency 17.0/25 · ROCE 15.7% · Operating margin 28.3% · 76% evidence Valuation 5.5/20 · P/E 21.5× · PEG 6.29 · 65% evidence Relative strength 12.2/20 · Lead over its industry -6.9% · Lead over S&P 500 0.5% · 1 year -21.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 21.4 + 17 + 5.5 + 12.2 = 56.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 9. [First Advantage Corporation](https://www.sectoralpha.in/us/stocks/fa) FA · quiet · Evidence leans up · 74% evidence 53.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.6/35 · Revenue 32.8% · Profit n/a · Operating margin change 2.6 points · 62% evidence Capital efficiency 9.2/25 · ROCE 4.9% · Operating margin 12.8% · 76% evidence Valuation 4.3/20 · P/E 123.1× · PEG 4.11 · 65% evidence Relative strength 14.7/20 · Lead over its industry 21.2% · Lead over S&P 500 29.7% · 1 year 63.9% · 100% evidence · 7 of 12 weeks ahead Exact sum: 25.6 + 9.2 + 4.3 + 14.7 = 53.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [LegalZoom.com, Inc.](https://www.sectoralpha.in/us/stocks/lz) LZ · turning · Evidence leans up · 74% evidence 53.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Revenue 12% · Profit -41.4% · Operating margin change 7 points · 62% evidence Capital efficiency 15.9/25 · ROCE 23.1% · Operating margin 5.4% · 76% evidence Valuation 3.9/20 · P/E 62.4× · PEG 9.26 · 65% evidence Relative strength 8.5/20 · Lead over its industry -17.4% · Lead over S&P 500 -10.7% · 1 year -33.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 24.8 + 15.9 + 3.9 + 8.5 = 53.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Global Payments Inc.](https://www.sectoralpha.in/us/stocks/gpn) GPN · turning · Evidence leans up · 71% evidence 52.7 out of 100 Growth Capital Valuation Relative
12. [Aramark](https://www.sectoralpha.in/us/stocks/armk) ARMK · turning · Evidence leans up · 64% evidence 52.0 out of 100 Growth Capital Valuation Relative
13. [TIC Solutions, Inc.](https://www.sectoralpha.in/us/stocks/tic) TIC · breaking out · Evidence leans down · 61% evidence 49.0 out of 100 Growth Capital Valuation Relative
14. [Eastman Kodak Company](https://www.sectoralpha.in/us/stocks/kodk) KODK · quiet · Evidence leans down · 64% evidence 47.8 out of 100 Growth Capital Valuation Relative
15. [Dolby Laboratories, Inc.](https://www.sectoralpha.in/us/stocks/dlb) DLB · losing its lead · Evidence leans down · 81% evidence 47.0 out of 100 Growth Capital Valuation Relative
16. [Rentokil Initial plc](https://www.sectoralpha.in/us/stocks/rto) RTO · basing · Too little evidence to rank firmly · 51% evidence 46.7 out of 100 Growth Capital Valuation Relative
17. [Transcat, Inc.](https://www.sectoralpha.in/us/stocks/trns) TRNS · quiet · Evidence leans down · 81% evidence 45.3 out of 100 Growth Capital Valuation Relative
18. [AZZ Inc.](https://www.sectoralpha.in/us/stocks/azz) AZZ · quiet · Evidence leans down · 85% evidence 45.0 out of 100 Growth Capital Valuation Relative
19. [Copart, Inc.](https://www.sectoralpha.in/us/stocks/cprt) CPRT · turning · Evidence leans down · 85% evidence 43.3 out of 100 Growth Capital Valuation Relative
20. [RB Global, Inc.](https://www.sectoralpha.in/us/stocks/rba) RBA · turning · Evidence leans down · 81% evidence 42.8 out of 100 Growth Capital Valuation Relative
21. [Target Hospitality Corp.](https://www.sectoralpha.in/us/stocks/th) TH · quiet · Evidence leans down · 64% evidence 42.2 out of 100 Growth Capital Valuation Relative
22. [Amentum Holdings, Inc.](https://www.sectoralpha.in/us/stocks/amtm) AMTM · basing · Evidence leans down · 64% evidence 40.7 out of 100 Growth Capital Valuation Relative
23. [Quad/Graphics, Inc.](https://www.sectoralpha.in/us/stocks/quad) QUAD · losing its lead · Evidence leans down · 64% evidence 40.4 out of 100 Growth Capital Valuation Relative
24. Cimpress plc this page CMPR · quiet · Evidence leans down · 64% evidence 36.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue 9.8% · Profit 100% · Operating margin change -2.1 points · 62% evidence Capital efficiency 13.6/25 · ROCE 17.5% · Operating margin 6.3% · 76% evidence Valuation 9.7/20 · P/E 25.7× · PEG n/a · 15% evidence Relative strength 0.6/20 · Lead over its industry -35.2% · Lead over S&P 500 -30.5% · 1 year -3.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 12.8 + 13.6 + 9.7 + 0.6 = 36.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 25. [BlackSky Technology Inc.](https://www.sectoralpha.in/us/stocks/bksy) BKSY · quiet · Evidence leans down · 64% evidence 36.6 out of 100 Growth Capital Valuation Relative
26. [UniFirst Corporation](https://www.sectoralpha.in/us/stocks/unf) UNF · quiet · Evidence leans down · 85% evidence 36.4 out of 100 Growth Capital Valuation Relative
27. [Resolute Holdings Management, Inc.](https://www.sectoralpha.in/us/stocks/rhld) RHLD · basing · Most evidence points down · 64% evidence 31.9 out of 100 Growth Capital Valuation Relative
28. [BrightView Holdings, Inc.](https://www.sectoralpha.in/us/stocks/bv) BV · turning · Most evidence points down · 71% evidence 30.4 out of 100 Growth Capital Valuation Relative
29. [Spire Global, Inc.](https://www.sectoralpha.in/us/stocks/spir) SPIR · quiet · Most evidence points down · 71% evidence 23.5 out of 100 Growth Capital Valuation Relative
30. [BUUU Group Limited](https://www.sectoralpha.in/us/stocks/buuu) BUUU · leader · Too little evidence to rank firmly · 42% evidence 49.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Specialty Business Services](https://www.sectoralpha.in/us/sectors/specialty-business-services), all 30 compared on one page. ## Which companies are close to Cimpress in size? Cimpress is the 19th largest of 31 Specialty Business Services companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: ABM Industries Incorporated, CBIZ, Inc. and TIC Solutions, Inc. Just below it: Target Hospitality Corp., BUUU Group and LegalZoom.com, Inc. ### Specialty Business Services companies close in size

1. [ABM Industries Incorporated](https://www.sectoralpha.in/us/stocks/abm) $3.1 billion
2. [CBIZ, Inc.](https://www.sectoralpha.in/us/stocks/cbz) $3 billion
3. [TIC Solutions, Inc.](https://www.sectoralpha.in/us/stocks/tic) $2.3 billion
4. Cimpress plc $1.5 billion
5. [Target Hospitality Corp.](https://www.sectoralpha.in/us/stocks/th) $1.4 billion
6. [BUUU Group Limited](https://www.sectoralpha.in/us/stocks/buuu) $1.2 billion
7. [LegalZoom.com, Inc.](https://www.sectoralpha.in/us/stocks/lz) $1.1 billion

[All 31 Specialty Business Services companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-business-services#all-companies)

### Companies close in size in other industries

1. [Atlanticus Holdings Corporation](https://www.sectoralpha.in/us/stocks/atlc) $1.4 billion · Credit Services
2. [Sharplink, Inc.](https://www.sectoralpha.in/us/stocks/sbet) $1.4 billion · Capital Markets
3. Cimpress plc $1.4 billion
4. [WeRide Inc.](https://www.sectoralpha.in/us/stocks/wrd) $1.4 billion · Software - Application
5. [AnaptysBio, Inc.](https://www.sectoralpha.in/us/stocks/anab) $1.4 billion · Biotechnology

## What else do people ask about Cimpress? ### What were Cimpress's latest quarterly results? Cimpress plc reported revenue of $945 M and net profit of $25.1 M for the Jun 2026 quarter. Earnings per share were $0.98. The operating margin was 6.3%, 2.1 percentage points lower than a year earlier (as of 3 November 2026). ### What is Cimpress's market cap? Cimpress plc's market capitalisation is $1.5 B at a stock price of $59.10. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Cimpress performing? Cimpress plc's share price has been moving sideways for 8 weeks. Over the past 13 weeks it has done worse than the S&P 500, for 14 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Cimpress's stock price go up? This page does not forecast Cimpress plc's stock price. What it shows instead: the stock price is $59.10, and it has been moving sideways for 8 weeks. Its P/E of 17.4× is higher than 36% of its own last 3 years (as of 3 November 2026). ### Is Cimpress's profit real cash? Yes, over the last 3 years, 328% of Cimpress plc's reported profit came in as cash from operations. The latest year was lower at 296%, so the trend is worth watching. In FY26, operating cash was $284 M against reported profit of $95.9 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is Cimpress in its business cycle? Cimpress plc's FY26 operating margin was 6.7%, against a 6-year range of 2.1% to 7.5%: the middle of its own range, neither a peak nor a low. The latest quarter was 6.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Cimpress story? The main question: yearly earnings per share moved +553.4% while the share price moved −14.6%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Cimpress a stock worth studying right now? What the numbers show: Cimpress plc's balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. The main open question: whether the business can earn its way back to positive net worth before new shares or a restructuring get there first. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.